STARBUCKS SAVES LIVES –
Sept. 26, 2024 – Regular coffee or caffeine consumption may offer a protective effect against developing multiple cardiometabolic diseases like coronary heart disease and stroke, the most common killers in human society today. Detailed in new research published in the Endocrine Society, three cups of coffee per day were associated with those in the study cohort who had a lower profile for a novel risk marker called “new-onset cardiometabolic multimorbidity.”
Cardiometabolic multimorbidity (CM) refers to the coexistence of at least two cardiometabolic diseases, and the prevalence of individuals with CM is becoming an increasing public health concern as populations age around the world, notes the study.
The COVID-19 pandemic showed that the burden of co-morbidities in high-income countries means that swaths of the population are at all times especially vulnerable to novel infections, particularly upper respiratory tract infections.
Coffee and caffeine consumption could play an important protective role in almost all phases of CM development, the researchers from China and Sweden found.
“Consuming three cups of coffee, or 200-300 mg caffeine, per day might help to reduce the risk of developing cardiometabolic multimorbidity in individuals without any cardiometabolic disease.”
